Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ada68032e6c5599de33d868231aaa52d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
filingDate |
2007-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1267bb5b62a9d264f5f414bca9c9ff7b |
publicationDate |
2007-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2007262064-A |
titleOfInvention |
Reducing the risk of chronic lung disease in infants |
abstract |
A method of reducing the risk of chronic lung disease without causing systemic side effects in an infant suffering from respiratory distress syndrome. A pharmaceutical composition comprising a combination of a corticosteroid and a pulmonary surfactant having high local anti-inflammatory activity relative to systemic anti-inflammatory activity. The corticosteroid is selected from the group consisting of ciclesonide, mometasone furancarboxylate, fluticasone propionate, and budesonide. The composition administered within 12 hours after birth of an infant. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190039102-A |
priorityDate |
2006-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |